Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fosun Orinove PharmaTech
Suzhou, Jiangsu, Chinafosunpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Fosun Orinove PharmaTech is a clinical-stage biotechnology company focused on the discovery and development of innovative small molecule therapeutics for oncology. A joint venture between Fosun Pharma and Orinove, the company leverages expertise in medicinal chemistry to target key pathways in cancer cell survival and proliferation, such as the BCL-2 family of proteins and various cyclin-dependent kinases. Its lead programs include dual BCL-2/BCL-xL inhibitors and selective CDK inhibitors designed to overcome resistance in both solid and hematological malignancies. The company is headquartered in Suzhou, China, and conducts clinical trials globally to address significant unmet needs in the cancer landscape.
- Therapeutic areas
- HematologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Fosun PharmaOrinove
Beyond the preview
Go deeper on Fosun Orinove PharmaTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fosun Orinove PharmaTech.